Esomeprazole Magnesium
Product Images NDC 68071-2917

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68071-2917). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2917 3)

Prescription bottle label for Esomeprazole Magnesium 40 mg delayed-release capsules, containing 30 capsules. Label includes manufacturer NuCare Pharmaceuticals, Inc., lot number and expiration date fields, storage temperature instructions, and warnings to keep out of reach of children. Label also references Dr. Reddy's Laboratories Limited and Orange Pharmaceuticals, Inc. as packagers and manufacturers.*

FDA Label Image

Figure1 (Figure1)

Chemical structure of esomeprazole magnesium shown as a dimer complex with magnesium ion and three water molecules. The structure includes two substituted pyridine rings with methoxy and methyl groups, linked by a sulfoxide and nitrogen bridges.*

FDA Label Image

Figure2 (Figure2)

A line graph depicting percentage maintained over six months for Esomeprazole Magnesium at 40 mg, 20 mg, 10 mg doses, and placebo. The y-axis shows percent maintained from 0 to 100%, and the x-axis represents time in months from 0 to 6. Four lines show the response trends for each dose and placebo group.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting percent maximal acid suppression over a 6-month period for Esomeprazole Magnesium at doses of 40 mg, 20 mg, and 10 mg compared with placebo. The y-axis shows percent maximal acidified, and the x-axis shows months from 0 to 6. Lines demonstrate higher acid suppression maintained by 40 mg and 20 mg doses compared to 10 mg and placebo groups.*

FDA Label Image

Figure4 (Figure4)

A line graph comparing the percent of patients symptom-free over a 28-day period among three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The x-axis represents diary days, and the y-axis shows the percent of patients symptom-free.*

FDA Label Image

Figure5 (Figure5)

A line graph showing the percent of patients symptom-free over 28 days (Diary Day) comparing Esomeprazole Magnesium 20 mg, 40 mg, and a placebo. The x-axis represents days from 0 to 28, and the y-axis represents the percent symptom-free from 0 to 100%.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.